Showing results (81-90 of 377) with videos related to

Sort By:
Pageof 38
Leukemia & Lymphoma|May 2, 2024
BRAF mutation in myeloid neoplasm: incidences and clinical outcomesTareq Abuasab, Shehab Mohamed, Naveen Pemmaraju, et al.
The Journal of Biological Chemistry|August 22, 2002
Radicicol-sensitive peptide binding to the N-terminal portion of GRP94Shawn Vogen, Tali Gidalevitz, Chhanda Biswas, et al.
Hematology/Oncology Clinics of North America|November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Blood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.
European Journal of Haematology|September 20, 2017
Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotypeWei Wang, Mark J Routbort, Zhenya Tang, et al.
Frontiers in Oncology|February 27, 2015
Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the LiteratureNaveen Pemmaraju, Koji Sasaki, Daniel Johnson, et al.
Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
American Journal of Clinical Pathology|June 15, 2016
Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid LeukemiaJuan Ouyang, Maitrayee Goswami, Jie Peng, et al.
Leukemia Research|July 30, 2013
Modest activity of pomalidomide in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
American Journal of Hematology|January 28, 2025
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid LeukemiaQing Wei, Shimin Hu, Sanam Loghavi, et al.
Pageof 38